Regina Hodits serves as Executive at Carisma Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Regina Hodits has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 7, 2023 involved receiving (via award) 2,297,546 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Mar 7, 2023 | CARM | $0 | Award | 2,297,546 | $N/A | Discretionary |
Regina Hodits currently holds 2,297,546 shares of Carisma Therapeutics Inc. (CARM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Regina Hodits has been a net neutral trader of CARM stock. They have purchased $0 and sold $0 worth of shares.
Regina Hodits's most recent insider trade was on Mar 7, 2023, when they sold 2,297,546 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted